Live News EQUITY FLASH L impact Oct 27, 2026, 01:08 PM UTC Capitainer Begins Clinical Sampling for HbA1c FDA 510(k) Study Capitainer has initiated clinical sampling for an HbA1c FDA 510(k) study. SquawkNews Desk